We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 961 results
  1. Molecular mechanisms by which the HIV-1 latent reservoir is established and therapeutic strategies for its elimination

    The human immunodeficiency virus type 1 (HIV-1) reservoir, composed of cells harboring the latent, integrated virus, is not eliminated by...

    Mateo Chvatal-Medina, Carolina Lopez-Guzman, ... Natalia A. Taborda in Archives of Virology
    Article 02 August 2023
  2. Single-Cell Single-Molecule RNA-FISH Combined with Immunofluorescence and High-Speed and High-Resolution Scanning Analysis to Visualize the Reactivation of Latent HIV-1

    Latent HIV-1 reservoirsHIV-1 reservoirs are a major obstacle to the eradication of HIV-1. Several cure strategies have been proposed to eliminate...
    Rajiv Pathak, Carolina Eliscovich, ... Ganjam V. Kalpana in HIV Protocols
    Protocol 2024
  3. An Ultrasensitive p24 Assay to Measure HIV-1 in Diverse Biological Matrixes

    Assays to study HIV persistence are crucial to evaluate therapeutic strategies aimed toward an HIV cure. Several assays have been developed to date...
    Callie Levinger, J. Natalie Howard, Alberto Bosque in HIV Protocols
    Protocol 2024
  4. Molecular Mechanisms of HIV-1 Latency from a Chromatin and Epigenetic Perspective

    Purpose of Review

    The main obstacle to an HIV-1 cure is the reservoir of HIV-1 infected cells. While antiretroviral therapy (ART) eliminates the HIV-1...

    Bianca B. Jütte, Luca Love, J. Peter Svensson in Current Clinical Microbiology Reports
    Article Open access 20 October 2023
  5. Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice

    Defining the latent human immunodeficiency virus type 1 (HIV-1) burden in the human brain during progressive infection is limited by sample access....

    Hang Su, Sruthi Sravanam, ... Prasanta K. Dash in Journal of Neuroimmune Pharmacology
    Article 15 September 2021
  6. The cell biology of HIV-1 latency and rebound

    Transcriptionally latent forms of replication-competent proviruses, present primarily in a small subset of memory CD4 + T cells, pose the primary...

    Uri Mbonye, Jonathan Karn in Retrovirology
    Article Open access 05 April 2024
  7. Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure

    Background

    Combination antiretroviral therapy (cART) has dramatically extended the life expectancy of people living with HIV-1 and improved their...

    Rafaëla Schober, Bianca Brandus, ... Carole Seguin-Devaux in Journal of Translational Medicine
    Article Open access 07 November 2023
  8. Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

    The persistence of CD4 + T cells carrying latent human immunodeficiency virus-1 (HIV-1) proviruses is the main barrier to a cure. New therapeutics to...

    Nathan L. Board, Zhe Yuan, ... Robert F. Siliciano in Nature Immunology
    Article Open access 26 January 2024
  9. Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR

    Despite the effectiveness of antiretroviral therapy (ART) in prolonging the lifespan of individuals infected with HIV-1, it does not offer a cure for...

    **-feng Cai, Jia-sheng Zhou, ... Kai Deng in Acta Pharmacologica Sinica
    Article 16 April 2024
  10. Brain HIV-1 latently-infected reservoirs targeted by the suicide gene strategy

    Reducing the pool of HIV-1 reservoirs in patients is a must to achieve functional cure. The most prominent HIV-1 cell reservoirs are resting CD4 + T...

    Sepideh Saeb, Mehrdad Ravanshad, ... Christian Schwartz in Virology Journal
    Article Open access 31 May 2021
  11. Occludin: a gatekeeper of brain Infection by HIV-1

    Compromised structure and function of the blood-brain barrier (BBB) is one of the pathological hallmarks of brain infection by HIV-1. BBB damage...

    Silvia Torices, Leah Daire, ... Michal Toborek in Fluids and Barriers of the CNS
    Article Open access 16 October 2023
  12. Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection

    Although previous studies have suggested that subtype B HIV-1 proviruses in the brain are associated with physiological changes and immune activation...

    Zhou Liu, Peter Julius, ... Charles Wood in Journal of NeuroVirology
    Article 28 June 2024
  13. Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures

    The human immunodeficiency virus (HIV) epidemic is an ongoing global health problem affecting 38 million people worldwide with nearly 1.6 million new...

    Martina Donadoni, Senem Cakir, ... Ilker K. Sariyer in Journal of NeuroVirology
    Article Open access 10 April 2024
  14. Defective HIV-1 genomes and their potential impact on HIV pathogenesis

    Defective HIV-1 proviruses represent a population of viral genomes that are selected for by immune pressures, and clonally expanded to dominate the...

    Jeffrey Kuniholm, Carolyn Coote, Andrew J. Henderson in Retrovirology
    Article Open access 28 June 2022
  15. Pericyte infection by HIV-1: a fatal attraction

    While HIV-1 is primarily an infection of CD4 + T cells, there is an emerging interest towards understanding how infection of other cell types can...

    Oandy Naranjo, Silvia Torices, ... Michal Toborek in Retrovirology
    Article Open access 07 December 2022
  16. Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models

    Background

    Despite antiretroviral treatment efficacy, it does not lead to the complete eradication of HIV infection. Consequently, reactivation of the...

    Lendel Correia da Costa, Larissa Maciel Bomfim, ... Amilcar Tanuri in Retrovirology
    Article Open access 22 June 2022
  17. Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda

    Background

    Our understanding of the peripheral human immunodeficiency virus type 1 (HIV-1) reservoir is strongly biased towards subtype B HIV-1...

    Samira Joussef-Piña, Immaculate Nankya, ... Miguel E. Quiñones-Mateu in Retrovirology
    Article Open access 15 January 2022
  18. Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection

    This review outlines the neuropathogenesis of HIV, from initial HIV entry into the central nervous system (CNS) to chronic infection, focusing on key...

    Lauren Killingsworth, Serena Spudich in Seminars in Immunopathology
    Article 26 July 2022
  19. Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family

    HIV-1-associated blood brain barrier (BBB) alterations and neurocognitive disorders are frequent clinical manifestations in HIV-1 infected patients....

    Silvia Torices, Timea Teglas, ... Michal Toborek in Molecular Neurobiology
    Article Open access 20 May 2023
  20. Inhibition of caspase pathways limits CD4+ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissue

    The study of HIV infection and pathogenicity in physical reservoirs requires a biologically relevant model. The human immune system (HIS) mouse is an...

    Alex J. Holloway, Tais B. Saito, ... Mark A. Endsley in Retrovirology
    Article Open access 02 May 2024
Did you find what you were looking for? Share feedback.